Nigrostriatal Dopaminergic Neurodegeneration in the Weaver Mouse Is Mediated via Neuroinflammation and Alleviated by Minocycline Administration

The murine mutant weaver (gene symbol, wv) mouse, which carries a mutation in the gene encoding the G-protein inwardly rectifying potassium channel Girk2, exhibits a diverse range of defects as a result of postnatal cell death in several different brain neuron subtypes. Loss of dopaminergic nigrostriatal neurons in the weaver, unlike cerebellar granule neuronal loss, is via a noncaspase-mediated mechanism. Here, we present data demonstrating that degeneration of midbrain dopaminergic neurons in weaver is mediated via neuroinflammation. Furthermore, in vivo administration of the anti-inflammatory agent minocycline attenuates nigrostriatal dopaminergic neurodegeneration. This has novel implications for the use of the weaver mouse as a model for Parkinson's disease, which has been associated with increased neuroinflammation.

[1]  Houeto Jean-Luc.  [Parkinson's disease]. , 2022, La Revue du praticien.

[2]  C. Borner.  Faculty Opinions recommendation of Reversal of Alzheimer's-like pathology and behavior in human APP transgenic mice by mutation of Asp664. , 2006 .

[3]  J. Andersen,et al.  Superoxide Dismutase/Catalase Mimetics Are Neuroprotective against Selective Paraquat-mediated Dopaminergic Neuron Death in the Substantial Nigra , 2005, Journal of Biological Chemistry.

[4]  Carlos Matute,et al.  Neuroprotection by tetracyclines. , 2004, Trends in pharmacological sciences.

[5]  J. Andersen,et al.  The Herbicide Paraquat Induces Dopaminergic Nigral Apoptosis through Sustained Activation of the JNK Pathway* , 2004, Journal of Biological Chemistry.

[6]  Andre Parent,et al.  Presence of reactive microglia in monkey substantia nigra years after 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine administration , 2003, Annals of neurology.

[7]  B. Liu,et al.  Novel anti-inflammatory therapy for Parkinson's disease. , 2003, Trends in pharmacological sciences.

[8]  Todd B. Sherer,et al.  Selective microglial activation in the rat rotenone model of Parkinson's disease , 2003, Neuroscience Letters.

[9]  J. Andersen,et al.  Inhibition of Caspases Protects Cerebellar Granule Cells of the Weaver Mouse from Apoptosis and Improves Behavioral Phenotype* , 2002, The Journal of Biological Chemistry.

[10]  G. Monaco,et al.  The Neurotoxin 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Induces Apoptosis in Mouse Nigrostriatal Glia , 2002, The Journal of Biological Chemistry.

[11]  S. Parvez,et al.  Apoptotic molecules and MPTP-induced cell death. , 2002, Neurotoxicology and teratology.

[12]  Dong-Kug Choi,et al.  Blockade of Microglial Activation Is Neuroprotective in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Mouse Model of Parkinson Disease , 2002, The Journal of Neuroscience.

[13]  M. Beal,et al.  Caspase-9 Activation Results in Downstream Caspase-8 Activation and Bid Cleavage in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Parkinson's Disease , 2001, The Journal of Neuroscience.

[14]  S. Paul,et al.  Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[15]  W. Le,et al.  Minocycline inhibits microglial activation and protects nigral cells after 6-hydroxydopamine injection into mouse striatum , 2001, Brain Research.

[16]  V. Viswanath,et al.  Transgenic mice neuronally expressing baculoviral p35 are resistant to diverse types of induced apoptosis, including seizure-associated neurodegeneration. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[17]  O. Andreassen,et al.  Mice Deficient in Cellular Glutathione Peroxidase Show Increased Vulnerability to Malonate, 3-Nitropropionic Acid, and 1-Methyl-4-Phenyl-1,2,5,6-Tetrahydropyridine , 2000, The Journal of Neuroscience.

[18]  T. Olsson,et al.  Expression of MHC class I heavy chain and β2-microglobulin in rat brainstem motoneurons and nigral dopaminergic neurons , 1999, Journal of Neuroimmunology.

[19]  J. Langston,et al.  Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine exposure , 1999, Annals of neurology.

[20]  B. Ghetti,et al.  A cell cycle alteration precedes apoptosis of granule cell precursors in the weaver mouse cerebellum. , 1999, The American journal of pathology.

[21]  A. Członkowska,et al.  The Inflammatory Reaction Following 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Intoxication in Mouse , 1999, Experimental Neurology.

[22]  S. Roffler-Tarlov,et al.  Girk2 expression in the ventral midbrain, cerebellum, and olfactory bulb and its relationship to the murine mutation weaver. , 1998, Developmental biology.

[23]  A. Lang,et al.  Parkinson's disease. First of two parts. , 1998, The New England journal of medicine.

[24]  E. Melamed,et al.  Transgenic mice expressing human Bcl-2 in their neurons are resistant to 6-hydroxydopamine and 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine neurotoxicity. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[25]  S. Roffler-Tarlov,et al.  Cell death during development of testis and cerebellum in the mutant mouse weaver. , 1998, Developmental biology.

[26]  D. Rosenbaum,et al.  Apoptosis in neurological disease. , 1998, Neurosurgery.

[27]  B. Ghetti,et al.  Diverse cell death pathways result from a single missense mutation in weaver mouse. , 1997, The American journal of pathology.

[28]  Wiklund Ra,et al.  First of two parts , 1997 .

[29]  K. Herrup,et al.  Failed Cell Migration and Death of Purkinje Cells and Deep Nuclear Neurons in the weaver Cerebellum , 1997, The Journal of Neuroscience.

[30]  R. Burke,et al.  Neuron Death in the Substantia Nigra of Weaver Mouse Occurs Late in Development and Is Not Apoptotic , 1996, The Journal of Neuroscience.

[31]  T. Dawson,et al.  Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[32]  A. Graybiel,et al.  Cell death in the midbrain of the murine mutation weaver , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[33]  L. Forno,et al.  Neuropathology of Parkinson's Disease , 1996, Journal of neuropathology and experimental neurology.

[34]  B. Ghetti,et al.  Detection of apoptosis in weaver cerebellum by electron microscopic in situ end-labeling of fragmented DNA , 1995, Neuroscience Letters.

[35]  David R. Cox,et al.  A potassium channel mutation in weaver mice implicates membrane excitability in granule cell differentiation , 1995, Nature Genetics.

[36]  Y. Soong,et al.  Ovum donation program at Chang Gung Memorial Hospital, Taipei. , 1992, Changgeng yi xue za zhi.

[37]  Richard E. Coggeshall,et al.  A consideration of neural counting methods , 1992, Trends in Neurosciences.

[38]  S. Perkins,et al.  Molecular comparisons of the beta 2-microglobulin-binding site in class I major-histocompatibility-complex alpha-chains and proteins of related sequences. , 1991, The Biochemical journal.

[39]  A. Graybiel,et al.  Patterns of cell and fiber vulnerability in the mesostriatal system of the mutant mouse weaver. I. Gradients and compartments , 1990, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[40]  Richard J Smeyne,et al.  Purkinje cell loss is due to a direct action of the weaver gene in Purkinje cells: evidence from chimeric mice. , 1990, Brain research. Developmental brain research.

[41]  Richard J Smeyne,et al.  Development and death of external granular layer cells in the weaver mouse cerebellum: a quantitative study , 1989, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[42]  P. Mcgeer,et al.  Reactive microglia are positive for HLA‐DR in the substantia nigra of Parkinson's and Alzheimer's disease brains , 1988, Neurology.

[43]  B. Ghetti,et al.  Mesencephalic dopamine cell deficit involves areas A8, A9 and A10 in weaver mutant mice , 1988, Experimental Brain Research.

[44]  K. Herrup,et al.  Regional differences in cytoarchitecture of the weaver cerebellum suggest a new model for weaver gene action , 1987, Neuroscience.

[45]  K Mizukawa,et al.  Anatomy and Pathology of the Basal Ganglia , 1987, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[46]  A. Graybiel,et al.  Expression of the weaver gene in dopamine-containing neural systems is dose-dependent and affects both striatal and nonstriatal regions , 1986, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[47]  G. Blatt,et al.  A qualitative and quantitative light microscopic study of the inferior olivary complex of normal, reeler, and weaver mutant mice , 1985, The Journal of comparative neurology.

[48]  A. Graybiel,et al.  Weaver mutation has differential effects on the dopamine-containing innervation of the limbic and nonlimbic striatum , 1984, Nature.

[49]  B. Ghetti,et al.  Dopamine deficiency in the weaver mutant mouse , 1982, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[50]  P. Rakić,et al.  Organization of cerebellar cortex secondary to deficit of granule cells in weaver mutant mice , 1973, The Journal of comparative neurology.

[51]  P. Rakić,et al.  Sequence of developmental abnormalities leading to granule cell deficit in cerebellar cortex of weaver mutant mice , 1973, The Journal of comparative neurology.

[52]  C. Yoon,et al.  Abnormal rate of granule cell migration in the cerebellum of "Weaver" mutant mice. , 1972, Developmental biology.

[53]  R. Snider.  Catalog of the Neurological Mutants of the Mouse , 1967, Neurology.

[54]  S. Hunot,et al.  Neuroinflammatory processes in Parkinson's disease , 2003, Annals of neurology.

[55]  P. Cresswell,et al.  Mechanisms of MHC class I--restricted antigen processing. , 1998, Annual review of immunology.

[56]  R. Coggeshall,et al.  Methods for determining numbers of cells and synapses: A case for more uniform standards of review , 1996, The Journal of comparative neurology.

[57]  P. Riederer,et al.  Brain beta 2-microglobulin levels are elevated in the striatum in Parkinson's disease. , 1995, Journal of neural transmission. Parkinson's disease and dementia section.

[58]  P. Riederer,et al.  Brain β2-microglobulin levels are elevated in the striatum in Parkinson's diseaselevels are elevated in the striatum in Parkinson's disease , 1995 .

[59]  P. Rakić,et al.  Mechanisms of cortical development: a view from mutations in mice. , 1978, Annual review of neuroscience.